📄 medicine

Clinical Application of a Dual-Threshold Bolus Tracking Protocol in One-Stop Combined CT Angiography and Venography of the Lower Extremities: A Prospective Comparative Observational Study

This prospective comparative study demonstrates that a personalized dual-threshold bolus tracking protocol significantly improves venous image quality and diagnostic yield in one-stop lower extremity CTA-CTV compared to a fixed-delay approach, while maintaining equivalent arterial enhancement and radiation dose.

Original authors: Qing-Peng Zhan, Shang-Ao Gong, Yu-Long Xie, Ting Wang, Hao Zhou, Chang-Zheng Shi

Published 2026-07-14

📖 4 min read☕ Coffee break read

CC BY 4.0

Original authors: Qing-Peng Zhan, Shang-Ao Gong, Yu-Long Xie, Ting Wang, Hao Zhou, Chang-Zheng Shi

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

Imagine your body's blood vessels as a massive, bustling highway system. Sometimes, traffic jams (blockages) happen in the arteries, and sometimes, the return lanes (veins) get clogged up too. To fix these problems, doctors need a super-clear map of the whole road network. Usually, getting this map with a CT scan is like trying to take a photo of a race car and a slow-moving truck at the exact same moment. If you press the shutter too early, you miss the truck; too late, and the car has zoomed past.

For a long time, doctors used a "fixed timer" to take these pictures. They'd say, "Okay, inject the dye, wait exactly 165 seconds, and click!" But here's the problem: everyone's heart beats at a different speed, and their blood flows at different rates. For some patients, 165 seconds is perfect. For others, it's a disaster—the truck (vein) hasn't even arrived at the intersection yet, or the car (artery) has already left town.

In this study, a team of researchers at Jinan University tried a new, smarter approach called a Dual-Threshold Bolus Tracking Protocol. Think of this not as a rigid timer, but as a high-tech traffic controller with two sets of eyes.

The Old Way vs. The New Way
The researchers split 68 patients with suspected leg vascular issues into two groups.

The Control Group (The Old Timer): These patients got the standard treatment. The scanner waited a fixed 165 seconds after the dye was injected before snapping the picture of the veins.
The Experimental Group (The Smart Controller): These patients got the new "dual-threshold" system. The scanner had two specific checkpoints:
1. Checkpoint 1 (The Artery): A sensor watched the abdominal aorta (the main highway). As soon as the dye hit a brightness level of 150 HU (a specific measure of how white the dye looks on the scan), the scanner knew, "Okay, the arterial race car is here!" It waited a tiny 8 seconds and then took the first picture.
2. Checkpoint 2 (The Vein): A second sensor watched the popliteal vein (a major return road behind the knee). It waited until the dye reached 120 HU. The moment the dye hit that level, the scanner said, "The venous truck has arrived!" and immediately took the second picture.

What They Found
The results were like night and day for the veins, while the arteries stayed just as good.

The Arteries: Both groups got excellent pictures of the arteries. The "smart controller" didn't mess up the car photo just because it was waiting for the truck. The brightness levels were high and clear for everyone.
The Veins: This is where the magic happened. In the "fixed timer" group, only 55.9% of the vein pictures were good enough to diagnose a problem. Many were blurry or missed the target entirely. But in the "smart controller" group, 88.2% of the vein pictures were diagnostic quality!
The Numbers: The "smart" group's vein pictures were significantly brighter (average 156.9 ± 17.6 HU vs. 122.0 ± 11.1 HU) and had much better contrast against the background noise.

Why This Matters (And What It Doesn't)
The authors suggest that this method works because it stops guessing and starts listening to the patient's own body. Instead of forcing a patient's unique blood flow to fit a standard clock, the scanner adapts to the patient's specific rhythm.

However, the paper is careful not to claim this solves every problem. They explicitly state that this study was about image quality, not about whether the new method cures diseases better than the old one. They also note that while the results are promising, we don't know yet if this works perfectly for everyone, especially people with very complex heart conditions or metal implants, because this study only looked at a specific group of 68 people.

Furthermore, the study confirms that this new method didn't increase the radiation dose. The "smart" scanner didn't need to blast more X-rays to get a better picture; it just needed to press the shutter button at the right moment.

The Bottom Line
This study suggests that by using a dual-sensor system to watch the dye flow in real-time, doctors can get much clearer maps of the veins in a patient's legs without hurting the quality of the artery maps or exposing the patient to more radiation. It turns a rigid, one-size-fits-all process into a flexible, personalized one, ensuring that when the doctor looks for a blockage, the "truck" is actually in the frame.

Technical Summary: Dual-Threshold Bolus Tracking in One-Stop Lower Extremity CTA-CTV

Problem Statement
The increasing prevalence of peripheral vascular disease (PVD), particularly in aging populations, necessitates accurate and early diagnosis. While Computed Tomography Angiography (CTA) is the preferred non-invasive modality for evaluating lower extremity vasculature, current "one-stop" protocols that attempt to image both arterial and venous systems simultaneously face significant limitations. Traditional approaches rely on fixed or empirical scan delays. These static protocols fail to accommodate individual hemodynamic variations caused by differences in cardiac function or the severity of vascular obstruction. Consequently, this often leads to suboptimal capture of either the arterial or venous phase, resulting in non-diagnostic images, particularly in the venous system where timing mismatches are frequent. Furthermore, performing separate scans for CTA and CT Venography (CTV) increases radiation exposure and contrast burden, violating the ALARA (As Low As Reasonably Achievable) principle.

Methodology
This prospective comparative observational study enrolled 68 patients with suspected lower extremity vascular disease, randomly assigning them to an experimental group or a control group (34 patients each). All subjects underwent scanning on a 256-slice CT scanner using a dual-phase injection protocol (95 mL iopromide followed by saline).

Control Group: Utilized a standard fixed-delay protocol. The arterial phase was triggered by a bolus tracking threshold of 150 HU in the distal abdominal aorta with an 8-second delay. The venous phase was acquired using a fixed 165-second delay post-injection.
Experimental Group: Employed a personalized dual-threshold bolus tracking protocol.
- Arterial Phase: Identical to the control group (150 HU threshold in the distal abdominal aorta).
- Venous Phase: A second monitoring Region of Interest (ROI) was placed at the popliteal vein. Monitoring began 90 seconds post-injection. The venous scan was dynamically triggered only when the popliteal vein attenuation reached a specific threshold of 120 HU. This approach allowed the scan initiation to respond to real-time venous opacification rather than a predetermined time.

Image quality was evaluated both objectively (CT attenuation, Signal-to-Noise Ratio [SNR], and Contrast-to-Noise Ratio [CNR]) and subjectively by two blinded radiologists using a 4-point diagnostic scale. Radiation dose (DLP and Effective Dose) was also recorded.

Key Results

Arterial Quality: There were no statistically significant differences between the two groups regarding arterial phase image quality. Both objective metrics (attenuation, SNR, CNR) and subjective scores remained comparable, indicating that the dual-threshold strategy did not compromise arterial enhancement.
Venous Quality: The experimental group demonstrated significantly superior venous image quality compared to the control group.
- Objective Metrics: The mean CT attenuation in the popliteal vein was significantly higher in the experimental group (156.9 ± 17.6 HU) versus the control group (122.0 ± 11.1 HU) ( $P < 0.001$ ). Similarly, the Contrast-to-Noise Ratio (CNR) was markedly improved in the experimental group (11.5 ± 2.5 vs. 7.1 ± 1.7, $P < 0.001$ ).
- Subjective Scores: The proportion of diagnostic-quality venous images (score $\ge$ 3) was 88.2% in the experimental group, significantly higher than the 55.9% observed in the control group ( $P < 0.001$ ).
Radiation Dose: No significant differences were found in radiation dose parameters (DLP and Effective Dose) between the groups, confirming that the improved image quality was achieved without increasing radiation exposure.

Significance and Claims
The authors claim that this study validates a personalized scanning protocol that effectively resolves the timing mismatch inherent in inter-individual circulatory variations. By shifting from rigid, standardized delays to a dynamic, physiology-driven trigger logic, the dual-threshold protocol successfully optimizes venous phase capture while maintaining conventional arterial enhancement levels.

The study concludes that this approach offers a highly efficient and robust solution for combined lower extremity arteriovenous imaging. It addresses the clinical challenge of non-diagnostic venous images in one-stop protocols without increasing radiation dose or contrast load. The authors emphasize that individualized scan timing driven by physiological feedback is a critical, independent variable for improving vascular CNR, comparable in importance to technical parameter adjustments like tube voltage reduction. While the study establishes feasibility and image quality benefits, the authors modestly note that generalizability to complex hemodynamic conditions and broader populations requires further validation in larger multicenter cohorts.

Technical Summary: Dual-Threshold Bolus Tracking in One-Stop Lower Extremity CTA-CTV

More like this